Magnesium Mood Meta-analysis: What the Evidence Says

Quick Answer

Magnesium Mood Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Depressive symptoms frequently co-occur in patients with CAD and are associated with adverse clinical outcomes, including reduced treatment adherence and increased cardiovascular risk. [Baran Jakub Marek (2026); evidence level 1]
• Depression is particularly common following acute coronary events, with reported prevalence rates ranging from approximately 20% to 40%, and has been consistently associated with increased risk of recurrent cardiovascular events and mortality. [Baran Jakub Marek (2026); evidence level 1]
• A comprehensive review of psychiatric presentations reported that psychiatric symptoms span attention problems, anxiety, mood/behavioral disorders, and psychosis and identified > 100 IEMs associated with psychiatric manifestations; in a curated analysis, 94 IEMs were linked to psychiatric symptoms, with mood changes ranging from depressive syndromes to bipolar-like presentations. [Hachmeriyan Antoniya (2026); evidence level 3]
• Clinically, mood disorders associated with IEMs often exhibit characteristic diagnostic patterns that may aid early recognition. [Hachmeriyan Antoniya (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium mood meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Baran Jakub Marek (2026). Trace Elements and Depressive Symptoms in Coronary Artery Disease: A Systematic Review of Sparse and Predominantly Indirect Evidence. DOI: 10.3390/ijms27093805. PMCID: PMC13164162. PMID: 42123390. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13164162/
• Hachmeriyan Antoniya (2026). From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression. DOI: 10.3390/nu18091318. PMCID: PMC13165168. PMID: 42123920. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165168/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.